Gross Revenue of US$98.64 Million and Cash Cost of US$814/OzVANCOUVER, British Columbia, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Monument Mining Limited (TSX-V: MMY and FSE: D7Q1) “Monument” or the “Company” today announced its annual financial results for the year ended June 30, 2025 (“Fiscal 2025” or “FY 2025”). All amounts are in United States dollars unless otherwise indicated (refer to www.sedar.com for full financial results). Fiscal 2025 gold production generated gross revenue of $98.64 million, compared t ...

Core Viewpoint - Constellation Software Inc. has announced the acquisition of TECVIA Holding GmbH by its Harris operating group, pending closing conditions [1]. Company Overview - Constellation Software Inc. specializes in acquiring, managing, and building vertical market software businesses that deliver mission-critical software solutions [1].

MONTREAL, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Rogers Sugar Inc. (RSI) will be holding a conference call to discuss their 2025 fourth quarter results on Thursday, November 27, 2025, at 8:00 a.m. (Eastern Time). The conference call will be chaired by Mr. Michael Walton, Chief Executive Officer and Mr. Jean-Sébastien Couillard, Chief Financial Officer. If you wish to participate, please dial 1-800-717-1738. A recording of the conference call will be accessible shortly after the conference, by dialing 1-888-660- ...

Core Viewpoint - OSE Immunotherapeutics reported a significant decline in financial performance for the first half of 2025, with revenues dropping from €69.0 million in H1 2024 to €1.3 million in H1 2025, primarily due to the deferred recognition of licensing income and a lack of exceptional income compared to the previous year [2][7][8]. Financial Performance - Revenues for H1 2025 were €1.3 million, a decrease of 98.1% from €69.0 million in H1 2024 [2]. - Operating income fell to €1.3 million in H1 2025 from €82.6 million in H1 2024, reflecting the deferred recognition of a portion of the AbbVie licensing agreement [2][7]. - The net loss for H1 2025 was €15.1 million, compared to a profit of €57.2 million in H1 2024 [8]. Expenses - Research and development expenses increased by 6.7% to €14.8 million in H1 2025 from €13.9 million in H1 2024, driven by ongoing development programs [3]. - General and administrative expenses rose by 5.0% to €4.5 million in H1 2025, primarily due to increased legal fees related to governance changes [4]. - Share-based payments expenses increased to €2.2 million in H1 2025 from €1.1 million in H1 2024, reflecting non-cash expenses under IFRS2 [5]. Cash Flow and Position - Net cash flows from operating activities were negative at €(19.2) million in H1 2025, a significant decline from €66.4 million in H1 2024 [9]. - Net cash flows from investment activities were positive at €30.4 million in H1 2025, compared to a negative €(54.9) million in H1 2024 [10]. - Cash and cash equivalents at the end of H1 2025 were €25.4 million, slightly down from €25.9 million in H1 2024, with total cash position decreasing to €41.6 million from €64.2 million [11]. Future Outlook - The company estimates its cash runway extends until the beginning of Q4 2026, factoring in potential warrant exercises but excluding future milestone payments [12]. - To extend its runway, the company is exploring options such as new strategic partnerships, equity financing, and restructuring existing debt [13]. - The interim financial statements were prepared on a going concern basis, indicating material uncertainty regarding the company's ability to continue operations without additional funding [14].

Core Insights - EssilorLuxottica has acquired Ikerian AG, operating under the RetinAI brand, to enhance its capabilities in AI and data management within eyecare [1][2] - The acquisition aims to strengthen the Group's med-tech journey by integrating advanced software that utilizes machine learning and computer vision to improve clinical workflows and patient care [1][3] Company Overview - RetinAI specializes in developing tools for collecting, processing, and grading large-scale retinal images and biomarker datasets, with its flagship platform, RetinAI Discovery, being FDA cleared and CE-marked [2] - The platform supports the diagnosis and monitoring of diseases such as age-related macular degeneration (AMD), glaucoma, and diabetic retinopathy, facilitating timely and accurate decision-making in eye disease management [2] Strategic Goals - The acquisition is part of EssilorLuxottica's broader strategy to create a digitally enabled patient journey, enhancing its ecosystem that includes eyecare, diagnostics, therapeutic innovation, and surgical excellence [3] - The integration of RetinAI's AI-powered analytics is expected to transform clinical data into actionable insights, leading to faster diagnoses and improved disease monitoring [3] Leadership Perspectives - Francesco Milleri, Chairman and CEO of EssilorLuxottica, emphasized the transformative potential of this acquisition for patient care and the healthcare industry as a whole [3] - Carlos Ciller, Chairman and CEO of RetinAI/Ikerian AG, highlighted the opportunity to scale their vision of data and AI-driven patient care through EssilorLuxottica's global reach and commitment to innovation [4]

COMPLETION OF SOCIETE GENERALE’S EUR 1 BILLION SHARE BUY-BACK PROGRAMME FOR CANCELLATION PURPOSE Regulated Information Paris, 15 October 2025 (In accordance with article 5 of Regulation (EU) No 596/2014 on Market Abuse Regulation and article 3(3) of Delegated Regulation (EU) 2016/1052 supplementing Regulation (EU) No 596/2014 through regulatory technical standards concerning the conditions applicable to buy-back programmes and stabilisation measures) Societe Generale announces the completion of its share b ...

Core Points - JP Morgan Asset Management Holdings Inc. has crossed the legal threshold of 3% for direct voting rights in Umicore, reaching a total holding of 3.43% as of October 9, 2025 [2][9]. Company Overview - Umicore is a global advanced materials and recycling group, specializing in transforming precious and critical metals into functional technologies for everyday applications [6]. - The company operates under a unique circular business model that focuses on refining and recycling critical elements for reintegration into new applications [6]. Business Segments - Umicore has four main business groups: Catalysis, Recycling, Specialty Materials, and Battery Materials Solutions, which address resource scarcity and the demand for functional materials in clean technologies and mobility [7]. - The company generates most of its revenue and R&D efforts from clean mobility and recycling, aiming for sustainable value creation through the development and recycling of materials [8]. Financial Performance - In the first half of 2025, Umicore reported group revenues (excluding metal) of €1.8 billion, with a total turnover of €8.7 billion [10].

Core Insights - Rapid7 has been recognized for the seventh consecutive year in the 2025 Gartner Magic Quadrant™ for Security Information and Event Management (SIEM) [1] - The company aims to enhance its SIEM capabilities with the launch of Incident Command, an AI-native solution designed to improve security operations [3][4] Company Overview - Rapid7, Inc. (NASDAQ: RPD) focuses on threat detection and exposure management, serving over 11,000 global customers [8] - The company is committed to simplifying cybersecurity and making it more accessible through integrated solutions [7] Product Development - Rapid7's SIEM solution, InsightIDR, is built on a security-role interface and an analyst-first experience, continuously validated by the company's own Security Operations Center (SOC) [2] - The recent launch of Incident Command aims to unify visibility, collaboration, and rapid response across the attack surface, enhancing the overall security posture [4] Market Recognition - In addition to the Gartner recognition, Rapid7 has received accolades from Forrester, Frost Radar™, and IDC for its vulnerability management and exposure management solutions [2] - The company's commitment to reducing alert fatigue and centralizing investigation workflows is reflected in its product offerings [3][4]

Press releaseParis, 15 October 2025 Bouygues Telecom, Free-iliad Group and Orange joint statement following the rejection of their acquisition bid by Altice France Bouygues Telecom, Free-iliad Group and Orange have taken note of the Altice group's decision to reject their joint non-binding offer submitted on the evening of 14 October to acquire a large part of Altice France's telecoms activities. The three operators remain convinced of the relevance of their bid and of the value of the project they are purs ...

Press release Paris, 15 October 2025 Bouygues Telecom, Free-iliad Group and Orange joint statement following the rejection of their acquisition bid by Altice France Bouygues Telecom, Free-iliad Group and Orange have taken note of the Altice group's decision to reject their joint non-binding offer submitted on the evening of 14 October to acquire a large part of Altice France's telecoms activities. The three operators remain convinced of the relevance of their bid and of the value of the project they are pur ...